Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
FutureSearch Clinical Trials
mi
from
Austin, TX
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
FutureSearch Clinical Trials
mi
from
Austin, TX
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Status: Archived
City of Brownsville
mi
from
Brownsville, TX
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Status: Archived
Updated: 1/1/1970
City of Brownsville
mi
from
Brownsville, TX
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Status: Archived
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Tu Salud Si Cuenta Worksite: Pilot Intervention Study
Status: Archived
Updated: 1/1/1970
Stony Brook University Hospital and Medical Center
mi
from
Stony Brook, NY
Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep
Neurobiological Correlates of PTSD During REM Sleep (REM-P)
Status: Archived
University of Pittsburgh
mi
from
Pittsburgh, PA
Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep
Neurobiological Correlates of PTSD During REM Sleep (REM-P)
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
Neuro-Genetic Markers of SSRI Treatment Response in Social Anxiety Disorder
Status: Archived
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
Neuro-Genetic Markers of SSRI Treatment Response in Social Anxiety Disorder
Status: Archived
Updated: 1/1/1970
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Lincoln Medical Center
mi
from
Lincoln, NE
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Lincoln Medical Center
mi
from
Lincoln, NE
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Sacramento, CA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Sacramento, CA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site 021
mi
from
San Francisco, CA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 021
mi
from
San Francisco, CA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Boca Raton, FL
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Boca Raton, FL
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Chicago, IL
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Chicago, IL
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
University of Pittsburgh and University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
University of Pittsburgh and University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Sheppard Pratt Health System
mi
from
Baltimore, MD
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Sheppard Pratt Health System
mi
from
Baltimore, MD
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Manhasset, NY
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Manhasset, NY
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Cleveland, OH
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Cleveland, OH
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative
mi
from
Enid, OK
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative
mi
from
Enid, OK
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Oklahoma City, OK
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Oklahoma City, OK
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Forest Investigative Site
mi
from
Pittsburgh, PA
Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Pittsburgh, PA
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models
Status: Archived
Boston Med Center
mi
from
Boston, MA
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Nurture: A Program for Mothers With Histories of Disordered Eating
Breaking the Cycle of Risk: Intervention for Mothers With Eating Disorders
Status: Archived
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Nurture: A Program for Mothers With Histories of Disordered Eating
Breaking the Cycle of Risk: Intervention for Mothers With Eating Disorders
Status: Archived
Updated: 1/1/1970
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Disulfiram Interactions With HIV Medications: Clinical Implications
Disulfiram Interactions With HIV Medications: Clinical Implications
Status: Archived
San Francisco General Hospital
mi
from
San Francisco, CA
Disulfiram Interactions With HIV Medications: Clinical Implications
Disulfiram Interactions With HIV Medications: Clinical Implications
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
mi
from
San Francisco, CA
Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
Healthy Lifestyle in Adults With ADHD
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
Healthy Lifestyle in Adults With ADHD
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Status: Archived
Sheehan Memorial Hospital
mi
from
Buffalo, NY
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Status: Archived
Updated: 1/1/1970
Sheehan Memorial Hospital
mi
from
Buffalo, NY
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Status: Archived
Erie County Medical Center
mi
from
Buffalo, NY
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
Status: Archived
Updated: 1/1/1970
Erie County Medical Center
mi
from
Buffalo, NY
Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia
Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder
Status: Archived
VA Medical Center, San Francisco
mi
from
San Francisco, CA
Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia
Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder
Status: Archived
Updated: 1/1/1970
VA Medical Center, San Francisco
mi
from
San Francisco, CA
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
Status: Archived
Center for Addiction and Pregnancy
mi
from
Baltimore, MD
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
Status: Archived
Updated: 1/1/1970
Center for Addiction and Pregnancy
mi
from
Baltimore, MD
Oxytocin and Social Cognition in Schizophrenia
Oxytocin and Social Cognition in Schizophrenia
Status: Archived
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Oxytocin and Social Cognition in Schizophrenia
Oxytocin and Social Cognition in Schizophrenia
Status: Archived
Updated: 1/1/1970
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Status: Archived
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
No. Little Rock, AR
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Status: Archived
Updated: 1/1/1970
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
No. Little Rock, AR
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Status: Archived
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Perspectives on Enhancing Family Involvement in Treatment for PTSD
Status: Archived
Updated: 1/1/1970
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Using Cognitive Training to Improve Employment Programs for People With Severe Mental Illnesses
Cognitive Training to Improve Work Outcomes in Severe Mental Illness
Status: Archived
UC San Diego Medical Center
mi
from
San Diego, CA
Using Cognitive Training to Improve Employment Programs for People With Severe Mental Illnesses
Cognitive Training to Improve Work Outcomes in Severe Mental Illness
Status: Archived
Updated: 1/1/1970
UC San Diego Medical Center
mi
from
San Diego, CA
Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers
Home-Based Parent Training in ADHD Preschoolers
Status: Archived
New York University Langone Medical Center
mi
from
New York, NY
Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers
Home-Based Parent Training in ADHD Preschoolers
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
mi
from
New York, NY
Recovery Group for Women With Substance Use Disorders
Recovery Group for Women With Substance Use Disorders
Status: Archived
McLean Hospital
mi
from
Belmont, MA
Recovery Group for Women With Substance Use Disorders
Recovery Group for Women With Substance Use Disorders
Status: Archived
Updated: 1/1/1970
McLean Hospital
mi
from
Belmont, MA
Recovery Group for Women With Substance Use Disorders
Recovery Group for Women With Substance Use Disorders
Status: Archived
Stanley Street Treatment and Resources (SSTAR)
mi
from
Fall River, MA
Recovery Group for Women With Substance Use Disorders
Recovery Group for Women With Substance Use Disorders
Status: Archived
Updated: 1/1/1970
Stanley Street Treatment and Resources (SSTAR)
mi
from
Fall River, MA
Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers
Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers
Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Sulfasalazine on BOLD Response to Alcohol Cues
Effects of Sulfasalazine on BOLD Response to Alcohol Cues
Status: Archived
The Mind Research Network
mi
from
Albuquerque, NM
Effects of Sulfasalazine on BOLD Response to Alcohol Cues
Effects of Sulfasalazine on BOLD Response to Alcohol Cues
Status: Archived
Updated: 1/1/1970
The Mind Research Network
mi
from
Albuquerque, NM
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Ketamine Anesthesia to Enhance Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Unipolar or Bipolar Depression
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Ketamine Anesthesia to Enhance Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Unipolar or Bipolar Depression
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
A Study of Oxytocin in Children and Adolescents With Autistic Disorder
A Pilot Study of Oxytocin in Children and Adolescents With Autistic Disorder
Status: Archived
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
A Study of Oxytocin in Children and Adolescents With Autistic Disorder
A Pilot Study of Oxytocin in Children and Adolescents With Autistic Disorder
Status: Archived
Updated: 1/1/1970
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Effects of Stress-reducing Aromatherapy
Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults
Status: Archived
Oregon Health and Science University
mi
from
Portland, OR
Effects of Stress-reducing Aromatherapy
Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Substance Use and Fitness
Substance Use and Fitness: A Pilot Study of Contingency Management in Older Adults
Status: Archived
University of Connecticut Health Center
mi
from
Farmington, CT
Substance Use and Fitness
Substance Use and Fitness: A Pilot Study of Contingency Management in Older Adults
Status: Archived
Updated: 1/1/1970
University of Connecticut Health Center
mi
from
Farmington, CT
Improving Antihypertensive Medication Adherence
Improving Antihypertensive Medication Adherence
Status: Archived
University of Connecticut Health Center
mi
from
Farmington, CT
Improving Antihypertensive Medication Adherence
Improving Antihypertensive Medication Adherence
Status: Archived
Updated: 1/1/1970
University of Connecticut Health Center
mi
from
Farmington, CT
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
Status: Archived
McLean Hospital
mi
from
Belmont, MA
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
Status: Archived
Updated: 1/1/1970
McLean Hospital
mi
from
Belmont, MA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
University of California, Davis Medical Center
mi
from
Sacramento, CA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
University of California, Davis Medical Center
mi
from
Sacramento, CA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
University of California Davis Cancer Center
mi
from
Sacramento, CA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
University of California Davis Cancer Center
mi
from
Sacramento, CA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Pharmax Research Clinic
mi
from
Miami, FL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Pharmax Research Clinic
mi
from
Miami, FL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Lake Mary Pediatrics
mi
from
Orange City, FL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Lake Mary Pediatrics
mi
from
Orange City, FL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Institute for Juvenile Research
mi
from
Chicago, IL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Institute for Juvenile Research
mi
from
Chicago, IL
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
James Whitcomb Riley Hospital for Children
mi
from
Indianapolis, IN
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
James Whitcomb Riley Hospital for Children
mi
from
Indianapolis, IN